Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $44.61 ($1.8M) on 2018-11-02, disclosed to the SEC on 2018-11-02.
Scheduled sale ($1.8M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.92 | 14,400 | $632K | 36.0% |
| 2 | $44.08 | 918 | $40K | 2.3% |
| 3 | $44.42 | 4,500 | $200K | 11.4% |
| 4 | $44.56 | 17,800 | $793K | 45.2% |
| 5 | $44.61 | 918 | $41K | 2.3% |
| 6 | $45.18 | 1,100 |
| $50K |
| 2.8% |
| Total | $44.32 avg | 39,636 | $1.8M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |